Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

NCT03696784 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
19
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators